RITPBC
RITPBC was funded by a grant from the NIHR’s EME Programme to CI David Jones and team.
It was a single-centre phase II, double-blind, RCT comparing rituximab with placebo in fatigued Primary Biliary Cholangitis patients.
You can find out more here, from RITPBC’s award page, from it’s registration on ClinicalTrials.gov, or from it’s final report.